USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

Q: Where does Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences ranks #13,451 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 22 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Guangzhou ranks #13,451 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 11 technology areas.

#13,451
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.3/100): 11.7
avg claims per patent: -69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13451 · Foreign Corporation #13,451 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,451/49,997
PHOTO-FINISH Genesis Robotics…
CPC-FOCUS A61K · 11 areas
INNOV-THIN 30.3/100
CLAIMS-PAR 11.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -69% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genesis Robotics and Motion Technologies Canada, ULC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Guangzhou’s 30.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (36%) Velocity 0.7 pts (2%) Breadth 11.7 pts (39%) Claim depth 7.0 pts (23%)

Qualcomm Incorporated · highest

85
Guangzhou Institutes… · this assignee

30
3D Lighting… · lowest

7

What this shows Guangzhou's Innovation Score is 30.3/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Guangzhou?

Each dot is one of Guangzhou’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Guangzhou’s own 11.7 claims/patent is at or below the 11.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Guangzhou vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Guangzhou's grants concentrate

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences is a focused PatentsView assignee: 11 CPC subclasses with 68.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2022. By volume, Guangzhou sits between Genesis Robotics and Motion Technologies Canada, ULC and Heishin Ltd..

Guangzhou's three-year grant acceleration

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences shows 1 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Genesis Robotics…

22
Gestamp Hardtech…

22
Global Marketing…

22
Glydways

22
Hangzhou Chipjet…

22
HCL Italy S p A

22
Hefei BOE Display…

22
Heishin

22
Guangzhou Institu… ◀

22

What this shows Guangzhou holds 22 patents at rank #13,449, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Guangzhou

By rank, the assignees closest to #13,449 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Guangzhou's primary technology class.

Guangzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	9.1%
2016	4	18.2%
2017	3	13.6%
2018	2	9.1%
2019	5	22.7%
2020	2	9.1%
2021	2	9.1%
2022	1	4.5%
2025partial year	1	4.5%

Which technologies does Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C07D - Heterocyclic Compounds 10

C07K - Peptides 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12Y - Enzymes 1

C07C - Acyclic OR Carbocyclic Compounds 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences's patent record in context - here's where to go next.

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 68.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #13,451 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences against Genesis Robotics and Motion Technologies Canada, ULC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.